Diagnostic biomarkers for differentiating AQP4-IgG- negative NMOSD from other nervous system autoimmune disorders: a retrospective study
AQP4-IgG-negative NMOSD shows distinct clinical, imaging, and laboratory profiles compared to other nervous system autoimmune disorders. A multi-indicator diagnostic approach offers higher accuracy than single-marker diagnostics.
Authors
- Z. Liu
- Wencan Jiang (ORCID: https://orcid.org/0000-0003-1937-0397)
- Yaowei Ding (ORCID: https://orcid.org/0000-0003-3167-6241)
- L. Liu
- Haoran Li (ORCID: https://orcid.org/0000-0002-1718-8703)
- Guojun Zhang (ORCID: https://orcid.org/0000-0002-9805-2014)
- Lijuan Wang (ORCID: https://orcid.org/0000-0002-9797-0753)
- Chenxu Wang
- Xiaotong Li
- Chi Huang
- Siwen Li
- Menglue Zhang
- Yang Jiao
- Kelin Chen
Institutions
- Capital Medical University (CN)
- Beijing Tian Tan Hospital (CN)
- Medical Plus (CZ)
- National Institute of Quality (PE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-14
- DOI
- https://doi.org/10.3389/fimmu.2025.1637613
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Capital Medical University
- Beijing Tian Tan Hospital, Capital Medical University